Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chono, JP
Hideharu Chono, Tsukuba-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20110027365 | Patch Formulation For External Use - A patch formulation for external use where a basic drug, an organic acid and an organic acid salt are combined as essential components is disclosed. The basic drug is preferably in the form of its acid addition salt. The organic acid is preferably a carboxylic acid having carbon atoms of 2 to 7, and more preferably at least one acid selected from the group consisting of acetic, lactic, tartaric, citric, malic, benzoic and salicylic acids. The organic acid salt is preferably a metal salt of a carboxylic acid, and more preferably sodium acetate. | 02-03-2011 |
Hideto Chono, Moriyama-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20080206873 | COMPLEX - A complex comprising a double-stranded DNA containing a terminal repeated sequence originating in a retrovirus and a DNA having a base sequence which does not occur in this retrovirus and a retrovirus-origin protein component. | 08-28-2008 |
Hideto Chono, Shiga JP
| Patent application number | Description | Published |
|---|---|---|
| 20080293141 | Cell for Producing Retrovirus Vector - The N-acetylglucosaminyltransferase III activity is enhanced in a cell carrying retrovirus-origin gag-pol gene and env gene. By constructing a retrovirus vector with the use of the above cell, a retrovirus vector having a modified sugar chain structure can be obtained. The retrovirus vector constructed by this method shows a high infection efficiency particularly in the presence of a functional substance. | 11-27-2008 |
| 20090011485 | METHOD OF RETROVIRUS STORAGE - A method of retrovirus storage, characterized in that a retrovirus is sustained in the presence of a substance with retrovirus binding activity immobilized on a solid phase. Further, there is provided a retrovirus composition characterized in that a retrovirus in the form of binding to a substance with retrovirus binding activity is sealed in a container holding a solid phase having the substance with retrovirus binding activity immobilized thereon. | 01-08-2009 |
| 20100113566 | NUCLEIC ACID FOR TREATMENT OR PREVENTION OF IMMUNODEFICIENCY VIRUS INFECTION - A nucleic acid comprising a transcription regulation sequence whose transcription is induced by a trans-acting factor of a human immunodeficiency virus and a gene encoding a polypeptide having an endoribonuclease activity specific to single-stranded RNA, wherein the gene is located in such a position that the expression of the gene can be regulated by the transcription regulation sequence; a method for production of a cell showing an inhibited replication of a human immunodeficiency virus therein, the method comprising the step of introducing the nucleic acid into a cell; and a method for treatment or prevention of a human immunodeficiency virus infection. | 05-06-2010 |
| 20100136680 | BAGLIKE CONTAINER FOR CENTRIFUGATION AND METHOD OF GENE TRANSFER USING THE SAME - Baglike container ( | 06-03-2010 |
| 20100137415 | VECTOR FOR GENE THERAPY - The present invention provides a retroviral vector containing a transcription unit comprising a transcription regulatory sequence and a gene encoding a polypeptide having single-stranded RNA-specific endoribonuclease activity which is placed so that its expression can be controlled by the regulatory sequence, wherein the unit is placed so that the direction of the transcription of mRNA from the unit is opposite to the direction of transcription of the RNA genome of the retroviral vector. By using the vector constructed as described above, viral supernatant showing high gene transfer efficiency can be prepared. The retroviral vector of the present invention is useful for the treatment and/or prevention of cancers and virus infections. | 06-03-2010 |
Kelichi Chono, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20110268184 | INVERSE QUANTIZATION METHOD, INVERSE QUANTIZATION DEVICE, AND PROGRAM - Disclosed is an inverse quantization method that reverse-quantizes multiple quantized values as a set, obtaining a set of multiple inverse quantized values, said method being characterized in that the range of potential inverse quantized values for each quantized value is obtained using at least a signal other than that of the aforementioned quantized value, and in that the set of preliminary inverse quantized values for which the total variation norm is the minimum within the range of potential values for each inverse quantized value is obtained as the aforementioned set of reverse-quantized values. | 11-03-2011 |
Koji Chono, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090048310 | AGENT FOR PREVENTION/TREATMENT OF DISEASE CAUSED BY ACYCLOVIR-RESISTANT HERPESVIRUS - [Problems] To provide an agent useful for the prevention or treatment of various diseases associated with the infection with acyclovir-resistant viruses of the family Herpesviridae, specifically various infectious caused by herpes viruses, such as varicella associated with varicella-zoster virus infection, herpes zoster associated with recurrent infection with latent varicella-zoster virus, and herpes labialis, herpes encephalitis and genital herpes associated with HSV-1 and HSV-2 infection, and the like. | 02-19-2009 |
| 20110201659 | AGENT FOR PREVENTING OR TREATING ZOSTER-ASSOCIATED PAIN - The present invention relates to a pharmaceutical composition and method for preventing or treating a zoster-associated pain. The inventors found that an N-{2-[(4-substituted phenyl)amino]-2-oxoethyl}tetrahydro-2H-thiopyran-4-carboxamide compound useful as a varicella-zoster virus (VZV) unexpectedly has the effect to prevent an irreversible nerve degeneration accompanied by herpes virus infection, and therefore is also useful as an agent for preventing or treating zoster-associated pain, and thus accomplished the present invention. | 08-18-2011 |
Shigeomi Chono, Nanoku JP
| Patent application number | Description | Published |
|---|---|---|
| 20090009670 | Liquid crystal flow forming mechanism, method of forming same, and object moving mechanism using liquid crystal flow - A mechanism and a method for causing a flow of liquid crystal, which can be utilized industrially, and an object-moving mechanism, which makes use of the flow of liquid crystal, are provided. A mechanism for causing a flow of liquid crystal comprising (i) a channel “L” defined by at lease one wall surface “B,” (ii) liquid crystal “LC” which is put in the channel “L” and movable along said at least one wall surface “B”, and (iii) a means for turning the molecules “m” of the liquid crystal “LC” in a plane intersecting said at least one wall surface “B.” The mechanism makes use of the flow of the liquid crystal “LC” which is caused when the molecules “m” of the liquid crystal “LC” are turned. When the means for turning the molecules “m” of the liquid crystal “LC” turns the molecules “m” of the liquid crystal “LC” in a plane intersecting said at least one wall surface “B,” the liquid crystal “LC” flows along said at least one wall surface “B.” The flow of the liquid crystal “LC” can easily be utilized for making object-moving devices, sensors, actuators, etc. | 01-08-2009 |
Shigeomi Chono, Kochi JP
| Patent application number | Description | Published |
|---|---|---|
| 20110058114 | OBJECT-MOVING MECHANISM MAKING USE OF FLOW OF LIQUID CRYSTAL - An object-moving mechanism, which makes use of the flow of liquid crystal, is provided. A mechanism for causing a flow of liquid crystal comprising (i) a channel “L” defined by at least one wall surface “B,” (ii) liquid crystal “LC” which is put in the channel “L” and movable along said at least one wall surface “B”, and (iii) a means for turning the molecules “m” of the liquid crystal “LC” in a plane intersecting said at least one wall surface “B.” The mechanism makes use of the flow of the liquid crystal “LC” which is caused when the molecules “m” of the liquid crystal “LC” are turned. When the means for turning the molecules “m” of the liquid crystal “LC” turns the molecules “m” of the liquid crystal “LC” in a plane intersecting said at least one wall surface “B,” the liquid crystal “LC” flows along said at least one wall surface “B.” The flow of the liquid crystal “LC” can easily be utilized for making object-moving devices, sensors, actuators, etc. | 03-10-2011 |
Sumio Chono, Hokkaido JP
| Patent application number | Description | Published |
|---|---|---|
| 20110117026 | METHODS AND COMPOSITIONS FOR THE DELIVERY OF BIOACTIVE COMPOUNDS - The present invention provides compositions comprising delivery systems comprising a lipid vehicle, a bioactive compound, and a polyanionic carrier macromolecule that is not a carrier polynucleotide, wherein the lipid vehicle encapsulates the polynucleotide of interest and the polyanionic carrier macromolecule, and wherein the delivery system is essentially free of carrier polynucleotides. Compositions also include delivery systems comprising a lipid vehicle and a bioactive agent, wherein the lipid vehicle encapsulates the bioactive agent, and wherein the lipid vehicle comprises a covalent bilayer or a core supported bilayer comprising polycationic lipids. Other compositions provided herein comprise a delivery system comprising a polypeptide of interest and a means for delivering the polypeptide into a cell. Also provided herein are methods for making the delivery systems, methods for delivering bioactive compounds, methods for treating a disease or unwanted condition in a subject with the delivery systems, and methods for detecting apoptosis in a cell. | 05-19-2011 |
| 20110117141 | METHODS AND COMPOSITIONS COMPRISING NOVEL CATIONIC LIPIDS - Provided herein are novel cationic lipids, compositions comprising the cationic lipids, and methods of using the cationic lipids. In some claims, the cationic lipids have cytotoxic activity and can be used alone or in combination with a cytotoxic bioactive compound to kill a cell. In some of these claims, the cationic lipid enhances the cytotoxic activity of the cytotoxic bioactive compound. Methods for treating a subject afflicted with a disease or unwanted condition are provided, wherein the method comprises administering a delivery system comprising a novel cationic lipid to the subject. The invention further provides methods for making delivery systems comprising the novel cationic lipids of the invention. | 05-19-2011 |
Tomoaki Chono, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090216124 | ULTRASONIC DIAGNOSTIC APPARATUS AND IMAGE PROCESSING METHOD THEREOF - An ultrasonic diagnostic apparatus includes means for transmitting/receiving ultrasonic waves to/from an object to be examined and capturing a dynamic image of the object. | 08-27-2009 |
| 20100022877 | ULTRASONOGRAPHIC DEVICE - An ultrasonographic device includes a template conversion unit ( | 01-28-2010 |
| 20110082371 | MEDICAL IMAGE PROCESSING DEVICE AND MEDICAL IMAGE PROCESSING METHOD - An ultrasonic diagnostic, apparatusi in accordance with the invention includes: an image information obtaining section configured to obtain multiple medical images in which a living tissue of a subject to be tested is imaged; and an image recognition calculation section configured to obtain motion information of the living tissue from pixel values of medical images at different time phases of the obtained multiple medical images and classify the medical images into predetermined types based on the motion information. | 04-07-2011 |
| 20110178405 | ULTRASONIC DIAGNOSTIC APPARATUS AND IMAGE PROCESSING APPARATUS FOR ULTRASONIC DIAGNOSIS - An ultrasonic diagnostic apparatus including means that acquires a three-dimensional ultrasonic signal of an internal organ of an examinee, means that sets a direction of a two-dimensional standard cross-section of the internal organ; means that adjusts display parameter of an image of a site which an examinee intends to observe, means that generates a two-dimensional standard cross-sectional image from the three-dimensional ultrasonic signal on the basis of the set direction of the two-dimensional standard cross-section of the internal organ, means that generates an observation cross-sectional image and a rendering image from the three-dimensional ultrasonic signal on the basis of the display parameters of the adjusted image, and display means that combines and displays the two-dimensional standard cross-sectional image, the observation cross-sectional image and the rendering image. | 07-21-2011 |